Healthcare >> CEO Interviews >> May 29, 2000
DR. RALPH E. CHRISTOFFERSEN, PhD, joined RPI as its President and Chief
Executive Officer in June 1992. He formerly served as Senior Vice
President for Research at SmithKline Beecham, Vice President for
Discovery Research at The Upjohn Company, President of Colorado State
University, and Vice Chancellor for Academic Affairs and Professor of
Chemistry at the University of Kansas. He is currently a member of the
Genomica Corporation Board, the Colorado Biotechnology Association Board
and the Biotechnology Industry Organization (BIO) Board. He received an
Honorary Doctor of Law degree from Cornell College in 1983, the
Outstanding Research of the Year Award from the International Society of
Quantum Biology in 1981, and W. E. Upjohn Award for contributions in
biotechnology in 1988. Dr. Christoffersen received his Bachelor of
Science in Chemistry and Mathematics from Cornell College, and his PhD
in Chemistry from Indiana University. Dr. Christoffersen is married with
two adult children. Profile
company to set the stage for the readers?
Dr. Christoffersen: Ribozyme Pharmaceuticals was formed in 1992. At that
time the
